Class IITerminatedD-1542-2020
Drug recall · September 2, 2020
BusPIRone Hydrochloride Tablets recall
Why: Failed Impurity /Degradation Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
- Lots / codes
Lot # 32091002, exp. date May 2021
- Quantity
- 11,347 bottles
- Company
- Par Pharmaceutical Inc., Chestnut Ridge, NY
- Distribution
- Product was distributed to 9 major distributors throughout the United States.
- Initiated
- August 10, 2020 · Voluntary: Firm initiated
- Classified
- August 25, 2020
- Reported
- September 2, 2020
- Ended
- June 7, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Buspirone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.